Tech Company Financing Transactions
Seismic Therapeutic Funding Round
On 2/18/2022, Seismic Therapeutic announced $101 million in Series A funding from Lightspeed Venture Partners, Boxer Capital and GV.
Transaction Overview
Company Name
Announced On
2/18/2022
Transaction Type
Venture Equity
Amount
$101,000,000
Round
Series A
Investors
Lightspeed Venture Partners (Lead Investor)
private investors (Timothy Springer)
Proceeds Purpose
That funding will bankroll preclinical development for two main autoimmune programs and an expansion of Seismic's proprietary machine learning algorithm.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Watertown, MA Undisclosed
USA
Watertown, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Seismic Therapeutic is making a major shift in how immunology therapies are discovered and developed, enabled by machine learning. We are an expert team of drug developers integrating machine learning across the entire discovery process to open new, better and faster ways to make medicines for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alan Crane
Chief Executive Officer
Jo Viney
Chief Financial Officer
Edward Freedman
Chief Medical Officer
John Sundy
Chief Technical Officer
Nathan Higginson-Scott
Vice President
Kevin Otipoby
Browse more venture capital transactions:
Prev: 2/18/2022: BasiGo venture capital transaction
Next: 2/18/2022: Parade venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC transactions on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs